Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Author:
Silk Sarah E., Kalinga Wilmina F., Mtaka Ivanny M., Lilolime Nasoro S., Mpina Maximillian, Milando Florence, Ahmed Saumu, Diouf Ababacar, Mkwepu Fatuma, Simon Beatus, Athumani Thabit, Rashid Mohammed, Mohammed Latipha, Lweno Omary, Ali Ali M., Nyaulingo Gloria, Mwalimu Bakari, Mswata Sarah, Mwamlima Tunu G., Barrett Jordan R., Wang Lawrence T., Themistocleous Yrene, King Lloyd D.W., Hodgson Susanne H., Payne Ruth O., Nielsen Carolyn M., Lawrie Alison M., Nugent Fay L., Cho Jee-Sun, Long Carole A., Miura Kazutoyo, Draper Simon J., Minassian Angela M.ORCID, Olotu Ally I.
Reference63 articles.
1. World Malaria Report,2022 2. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial;Datoo;Lancet,2021 3. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial;Rts;Lancet,2015 4. Malaria Vaccines: Recent Advances and New Horizons;Draper;Cell Host Microbe,2018 5. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target;Ragotte;Trends Parasitol.,2020
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|